Phosphoinositide 3-kinase alpha, beta, delta, and gamma isoforms (PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ)

Phosphoinositide 3-kinase alpha, beta, delta, and gamma isoforms (PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ) are the four catalytic isoforms of Class I phosphoinositide 3-kinase, a family of lipid kinases involved in transmitting signals from receptors at the cell surface to phosphoinositide-dependent pathways inside the cell. These enzymes generate phosphatidylinositol (3,4,5)-trisphosphate, which recruits and activates proteins central to cell survival, proliferation, motility, and metabolism. Each isoform has unique tissue distribution and physiological roles: PI3Kα and PI3Kβ are ubiquitously expressed and essential for general cell functions, while PI3Kδ and PI3Kγ are mainly found in hematopoietic and immune cells, governing immune responses and inflammation. Mutations—particularly activating mutations in PIK3CA (the gene encoding PI3Kα)—play a pivotal role in oncogenesis, and pharmaceutical inhibition of these isoforms is a proven strategy in cancer and immune-related diseases. However, targeting these kinases presents clinical challenges related to immune suppression, metabolic toxicity, and on-target adverse effects, necessitating isoform-selective inhibitor development.

Other names

Class I phosphoinositide 3-kinaseClass I PI3K (p110α, p110β, p110δ, p110γ)PI3K p110 isoformsPIK3CA (alpha)PIK3CB (beta)PIK3CD (delta)PIK3CG (gamma)

Inhibition of PI3K catalytic activity Blockade of the PI3K/AKT/mTOR signaling pathway, leading to reduced cell survival and proliferation